BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 16160028)

  • 1. Flow-mediated vasodilation is mediated by endothelium-derived nitric oxide.
    Creager MA
    J Appl Physiol (1985); 2005 Oct; 99(4):1625. PubMed ID: 16160028
    [No Abstract]   [Full Text] [Related]  

  • 2. Flow-mediated vasodilation partially reflects nitric oxide-mediated endothelial function.
    Linke A; Erbs S; Hambrecht R
    J Appl Physiol (1985); 2005 Oct; 99(4):1622. PubMed ID: 16160025
    [No Abstract]   [Full Text] [Related]  

  • 3. In FMD, NO is actually "the middle man".
    Wray DW; Richardson RS
    J Appl Physiol (1985); 2005 Oct; 99(4):1624. PubMed ID: 16160027
    [No Abstract]   [Full Text] [Related]  

  • 4. FMD vs. pharmacological approaches for endothelial function.
    Tanaka H
    J Appl Physiol (1985); 2005 Oct; 99(4):1627. PubMed ID: 16160030
    [No Abstract]   [Full Text] [Related]  

  • 5. Flow-mediated dilation.
    Parker BA; Proctor DN
    J Appl Physiol (1985); 2005 Oct; 99(4):1620. PubMed ID: 16160023
    [No Abstract]   [Full Text] [Related]  

  • 6. Brachial artery FMD with 5-minute distal cuff occlusion--a useful pathophysiological test after all!
    Celermajer DS
    J Appl Physiol (1985); 2005 Oct; 99(4):1619. PubMed ID: 16160022
    [No Abstract]   [Full Text] [Related]  

  • 7. Flow-mediated dilation does/does not reflect nitric oxide-mediated endothelial function.
    Austin CE
    J Appl Physiol (1985); 2005 Oct; 99(4):1621. PubMed ID: 16160024
    [No Abstract]   [Full Text] [Related]  

  • 8. Endothelium-dependent brachial artery flow-mediated vasodilatation in patients with diabetes mellitus with and without coronary artery disease.
    Nanivadekar A
    J Assoc Physicians India; 2004 Sep; 52():759-60; author reply 760. PubMed ID: 15839462
    [No Abstract]   [Full Text] [Related]  

  • 9. Bimodal distribution of vasodilator responsiveness to adenosine due to difference in nitric oxide contribution: implications for exercise hyperemia.
    Martin EA; Nicholson WT; Eisenach JH; Charkoudian N; Joyner MJ
    J Appl Physiol (1985); 2006 Aug; 101(2):492-9. PubMed ID: 16614358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of sildenafil on nitric oxide-mediated vasodilation in healthy men.
    Dishy V; Sofowora G; Harris PA; Kandcer M; Zhan F; Wood AJ; Stein CM
    Clin Pharmacol Ther; 2001 Sep; 70(3):270-9. PubMed ID: 11557915
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Flow-mediated dilatation following wrist and upper arm occlusion in humans: the contribution of nitric oxide.
    Doshi SN; Naka KK; Payne N; Jones CJ; Ashton M; Lewis MJ; Goodfellow J
    Clin Sci (Lond); 2001 Dec; 101(6):629-35. PubMed ID: 11724650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Menstrual cyclic variation of endothelium-dependent vasodilation of the brachial artery: possible role of estrogen and nitric oxide.
    Kawano H; Motoyama T; Kugiyama K; Hirashima O; Ohgushi M; Yoshimura M; Ogawa H; Okumura K; Yasue H
    Proc Assoc Am Physicians; 1996 Nov; 108(6):473-80. PubMed ID: 8956371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myogenic vascular regulation in skeletal muscle in vivo is not dependent of endothelium-derived nitric oxide.
    Ekelund U; Björnberg J; Grände PO; Albert U; Mellander S
    Acta Physiol Scand; 1992 Feb; 144(2):199-207. PubMed ID: 1575052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Flow-mediated dilatation revisited.
    Joannides R; Bellien J
    J Appl Physiol (1985); 2005 Oct; 99(4):1623. PubMed ID: 16160026
    [No Abstract]   [Full Text] [Related]  

  • 15. Vascular distribution of nitric oxide synthase and vasodilation in the Australian lungfish, Neoceratodus forsteri.
    Jennings BL; Blake RE; Joss JM; Donald JA
    Comp Biochem Physiol A Mol Integr Physiol; 2008 Dec; 151(4):590-5. PubMed ID: 18692149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term association of brachial artery flow-mediated vasodilation and cardiovascular events in middle-aged subjects with no apparent heart disease.
    Shechter M; Issachar A; Marai I; Koren-Morag N; Freinark D; Shahar Y; Shechter A; Feinberg MS
    Int J Cardiol; 2009 May; 134(1):52-8. PubMed ID: 18479768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting the arterial wall, but what is the target?
    Shantsila E; Lim HS
    J Hum Hypertens; 2009 Jan; 23(1):1-3. PubMed ID: 18509342
    [No Abstract]   [Full Text] [Related]  

  • 18. Insulin-mediated blood flow and glucose uptake.
    Floras JS; Meneilly G
    Can J Cardiol; 2001 May; 17 Suppl A():7A-10A. PubMed ID: 11381287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The contribution of nitric oxide and vasodilatory prostanoids to bradykinin-mediated vasodilation in Type 1 diabetes.
    Wotherspoon F; Browne DL; Meeking DR; Allard SE; Munday LJ; Shaw KM; Cummings MH
    Diabet Med; 2005 Jun; 22(6):697-702. PubMed ID: 15910619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The relationship between shear stress and flow-mediated dilatation: implications for the assessment of endothelial function.
    Pyke KE; Tschakovsky ME
    J Physiol; 2005 Oct; 568(Pt 2):357-69. PubMed ID: 16051630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.